Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 20,000 shares at $4.28 ($85K) on 2008-01-03, disclosed to the SEC on 2008-01-07.
Open-market purchase of $85k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.21 | 100 | $421 | 0.5% |
| 2 | $4.22 | 400 | $2K | 2.0% |
| 3 | $4.23 | 400 | $2K | 2.0% |
| 4 | $4.24 | 300 | $1K | 1.5% |
| 5 | $4.25 | 3,300 | $14K | 16.4% |
| 6 | $4.26 | 5,500 |
| $23K |
| 27.4% |
| 7 | $4.27 | 3,500 | $15K | 17.5% |
| 8 | $4.28 | 2,300 | $10K | 11.5% |
| 9 | $4.29 | 400 | $2K | 2.0% |
| 10 | $4.30 | 800 | $3K | 4.0% |
| 11 | $4.31 | 800 | $3K | 4.0% |
| 12 | $4.32 | 200 | $864 | 1.0% |
| 13 | $4.33 | 600 | $3K | 3.0% |
| 14 | $4.34 | 800 | $3K | 4.1% |
| 15 | $4.35 | 500 | $2K | 2.5% |
| 16 | $4.36 | 100 | $436 | 0.5% |
| Total | $4.27 avg | 20,000 | $85K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |